Compare CHT & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHT | WAT |
|---|---|---|
| Founded | 1996 | 1958 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.5B | 33.5B |
| IPO Year | 2003 | 1996 |
| Metric | CHT | WAT |
|---|---|---|
| Price | $44.05 | $376.79 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $379.19 |
| AVG Volume (30 Days) | 125.3K | ★ 854.9K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.37 | $104.66 |
| Revenue Next Year | $3.23 | $10.40 |
| P/E Ratio | $26.66 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $39.28 | $275.05 |
| 52 Week High | $46.48 | $414.15 |
| Indicator | CHT | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 43.48 | 61.76 |
| Support Level | $43.78 | $372.18 |
| Resistance Level | $45.10 | $388.97 |
| Average True Range (ATR) | 0.57 | 10.43 |
| MACD | -0.23 | 0.54 |
| Stochastic Oscillator | 12.96 | 85.33 |
Chunghwa Telecom Co Ltd is Taiwan's integrated telecom operator, providing fixed-line, wireless, and Internet and data services. The company's reportable segments are: Consumer Business, Enterprise Business, International Business, and Others. The majority of its revenue comes from the Consumer Business, which focuses on individual and home-centric businesses, such as mobile, fixed broadband, Wi-Fi, IPTV (MOD), and OTT services. The Enterprise business offers IDC, cloud, cybersecurity, 5G, AIoT, data, AI, enterprise digital transformation, and system integration services to businesses, and the International business segment represents services offered to international customers. Geographically, the company generates maximum revenue from its business in Taiwan.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.